Blue Jet Healthcare renewable energy use up 28% in FY26
Blue Jet Healthcare’s FY26 BRSR reveals a 28% surge in renewable energy use to 40,836.79 GJ and an 8% drop in Scope 1 & 2 emissions. The company reused 48,827 KL of water via ZLD systems and reported zero workplace fatalities.
*this image is generated using AI for illustrative purposes only.
Blue Jet Healthcare Limited released its Business Responsibility and Sustainability Report (BRSR) for FY26 on August 18, 2026. The Navi Mumbai-based manufacturer of contrast media, high-intensity sweeteners, and pharmaceutical intermediaries highlighted significant progress in its environmental sustainability metrics during the reporting period.
The company reported a substantial shift in its energy mix, with renewable energy consumption rising by 28% year-on-year. Total renewable energy usage reached 40,836.79 GJ in FY26, up from 26,321.38 GJ in FY25. This increase was driven by the commissioning of a 5.625 MW solar power plant and the installation of a 3.2 MW windmill. Consequently, approximately 57% of the company’s total energy requirements are now met through renewable sources.
Environmental Performance
The expansion of renewable capacity contributed to a measurable decline in carbon emissions. Scope 1 and Scope 2 greenhouse gas emissions decreased to 32,138.47 tCO2e in FY26, down from 34,885.47 tCO2e in FY25. The company also implemented boiler efficiency monitoring and automatic coal combustion control systems, which resulted in a 5–8% reduction in specific emissions including CO2, NOx, and SOx.
Water management remains a critical focus for the chemical manufacturing entity. Blue Jet Healthcare operates a Zero Liquid Discharge (ZLD) system across its facilities. During FY26, the company treated and reused 48,827 KL of water through its Effluent Treatment Plant (ETP) and Reverse Osmosis (RO) systems. Treated water is recycled for utility applications such as cooling towers and boilers, reducing freshwater dependency.
| Environmental Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Renewable Energy Consumption: | 40,836.79 GJ | 26,321.38 GJ | +28% |
| Scope 1 & 2 Emissions: | 32,138.47 tCO2e | 34,885.47 tCO2e | -8% |
| Water Reused: | 48,827 KL | Not Disclosed | N/A |
Social and Governance Highlights
On the social front, the company maintained a workforce of 508 employees and 73 workers at the end of FY26. Women represented 37.5% of the Board of Directors and 50% of Key Managerial Personnel. The company reported zero Lost Time Injury Frequency Rate (LTIFR) and zero fatalities for employees and workers during the financial year.
Blue Jet Healthcare obtained reasonable assurance on its BRSR Core KPIs from TÜV India Private Limited. The company also initiated Scope 3 emissions accounting for selected categories in FY26, marking its first year of reporting under this framework. Exports accounted for approximately 90% of total turnover, with operations serving over 50 countries including the USA, Norway, and various European nations.
Historical Stock Returns for Blue Jet Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.64% | +2.82% | +4.16% | +68.24% | -22.06% | +47.28% |
How might Blue Jet Healthcare's 57% renewable energy mix position it competitively against peers facing stricter EU carbon border adjustment mechanisms?
What specific financial incentives or regulatory pressures are driving the company's expansion into Scope 3 emissions accounting, and how will this impact future supply chain contracts?
Given that 90% of turnover comes from exports, how vulnerable is Blue Jet Healthcare to potential shifts in global pharmaceutical demand or trade tariffs in key markets like the USA and Europe?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
